Preview

Ophthalmology in Russia

Advanced search

Methods of Screening for Meibomian Gland Dysfunction

https://doi.org/10.18008/1816-5095-2016-4-235-240

Abstract

The relevance of the modern diagnosis of meibomian glands dysfunction (MGD) increases daily. Firstly, it is caused by changing of the perception about the prevalence of this disease, according to various data it is from 40 to 71% of the population in different age groups. Considering the increasing number of patients suffering from MGD, there is the need to develop screening methods for diagnosis of this disease. Screening methods should be available not only for specialists involved in the treatment of xerosis keratoconjunctival in specialized ophthalmology clinics, but also in out-patient sector. An important aspect in the diagnosis of the severity of the functional
disorders of the meibomian glands is the assessment of morphological status that determines the further choice of therapy. To evaluate the morphological and functional state of the meibomian glands proposed to use biometrics of meibomian glands. A slit lamp is used for examination. Furthermore, objective data characterizing the morpho-functional state of the meibomian glands, can be obtained by carrying out meibography. Authors used not only white light but also infrared light for the visualization of meibomian glands during meibography. The multifunctional ophthalmic devices equipped with infrared lighting can be used for lighting. For example, specialized slit lamps, corneal topographs, Sheympflyug camera, the fundus camera and others. We applied nonmidriatic fundus camera TOPCON TRC-NW300, using for fotoregistration of the ocular fundus. A feature of the proposed method — meyboskopy — was simplicity and absence of necessity of the investigator skills by scanning with the fundus camera of the inner surface of the eyelid. Meiboskopy doesn’t require  additional equipment and software of the fundus camera and allows to receive objective quality video of meibomian glands, it opens new diagnostic possibilities. Extending of the range of diagnostic capabilities in detecting of MGD based on the screening methods will allow time to assess the severity of this disease and to appoint pathogenetically substantiated therapy.

About the Authors

V. N. Trubilin
Federal institute of the professional development, Federal medical and biological agency
Russian Federation
МD., рrofessor, Head of the Department of Ophthalmology


E. G. Polunina
Federal institute of the professional development, Federal medical and biological agency, Clinical Hospital Lapino “Mother and Child”
Russian Federation
MD, assistant professor of the Department of Ophthalmology


E. Yu. Markova
The S. Fyodorov Eye Microsurgery Federal State Institution
Russian Federation
MD, head of the of microsurgery and rehabilitation of the eye in children


D. V. Andzhelova
Research Institute of Eye Diseases,Scientific institution “The National Research Institute of Public Health named Semashko“
Russian Federation
MD, Senior Researcher


S. V. Kurenkova
The S. Fyodorov Eye Microsurgery Federal State Institution
Russian Federation
postgraduate


L. Yu. Bezmel’nitsyna
Scientific institution “The National Research Institute of Public Health named Semashko“
Russian Federation
Leading Researcher


References

1. Fogt JS, Kowalski MJ, King-Smith PE, Epitropolous AT, Hendershot AJ, Lembach C, Maszczak JP, Jones-Jordan LA, Barr JT.Tear lipid layer thickness with eye drops in meibomian gland dysfunction. Clin Ophthalmol. 2016;7(10):2237-2243.

2. Nebbioso M1, Fameli V, Gharbiya M, Sacchetti M, Zicari AM, Lambiase A. Investigational drugs in dry eye disease. Expert Opin Investig Drugs. 2016 Dec;25(12):1437-1446.

3. Rötzer V, Egu D, Waschke J.Meibomian gland cells display a differentiationdependent composition of desmosomes. Histochem Cell Biol. 2016 Dec;146(6):685- 694.

4. Kelly K. Nichols1, Gary N. Foulks, et al. The International Workshop on Meibo- mian Gland Dysfunction: Executive Sammary. Invest Ophthalmol Vis Sci. 2011;52:1922- 1929.

5. Shimazaki J., Sakata M., Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1999;113(10):1266-1270.

6. Yokoi N., Bron A., Tiffany J., Brown N., et al. Reflective meniscometry: a noninvasive method to measure tear meniscus curvature. Br.J. Ophthalmology. 1999;83:92-97.

7. Lucevich E. Je. Labidi A. [Biometrics of a plaintive stream as method of an assessment of basal secretion of a tear production. Modern methods of diagnostics and treatment of diseases of plaintive bodies]. Biometrija sleznogo ruch’ja kak metod ocenki bazal’noj sekrecii slezoprodukcii. Sovremennye metody diagnostiki i lech- enija zabolevanij sleznyh organov. 2005; М:, 190-195. (in Russ.)

8. Trubilin V.N., Polunina E.G., Alieva A.E., Kurenkov V.V., Zhemchugova A.V. [A new method of complex evaluation of meibomian glands morphological and functional state]. Novaya diagnosticheskaya metodika kompleksnoy otsenki morfofunktsional'nogo sostoyaniya meybomievykh zhelez — biometriya meybomievykh zhelez. [Ophthalmology]. Oftal'mologiya. 2014;11(2):39-47. (In Russ.) DOI:10.18008/1816-5095-2014-2-39-47. (In Russ.)

9. Trubilin V.N., Polunina E.G., Kurenkov V.M. [Ultrasound biomicroscopy as a tool for conjunctiva and eyelids evaluation]. Vozmozhnosti primeneniya ul'trazvukovoy biomikroskopii v otsenke sostoyaniya vek i kon»yunktivy. [Ophthalmology]. Oftal'mologiya. 2014;11(4):32-40. (In Russ.) DOI:10.18008/1816-5095-2014-4-32-40. (In Russ.)

10. Heiko Pult, Jason J. Nichols. A Review of Meibography. Optom Vis Sci. 2012;89:E760–E769 .

11. Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R, Dogru M. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–49.

12. Zhao Y, Veerappan A, Yeo S, Rooney DM, Acharya RU, Tan JH, Tong L. Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography. Eye Contact Lens. 2016 Nov;42(6):339-346.

13. Pult H, Riede-Pult BH. Non-contact meibography: keep it simple but effective. Cont Lens Anterior Eye. 2012;35:77–80.

14. Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Goto T, Negishi K, Tsubota K. The efficacy, sensitivity, and speci- ficity of in vivo laser confocal microscopy in the diagnosis of meibo- mian gland dysfunction. Ophthalmology. 2010;117:665–72.

15. Yokoi N, Komuro A, Yamada H, Maruyama K, Kinoshita S. A newly developed video-meibography system featuring a newly designed probe. Jpn J Ophthalmol.2007;51:53–6.

16. Matsuoka T, Tsumura T, Ueda H, Hasegawa E. [Video-meibographic observationsof the meibomian gland]. Rinsho Ganka. 1996;50:351–4.

17. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115:911–5.

18. Jester JV, Rife L, Nii D, Luttrull JK, Wilson L, Smith RE. In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1982;22:660–7.

19. McCann LC, Tomlinson A, Pearce EI, Diaper C. Tear and meibomian gland function in blepharitis and normals. Eye Contact Lens. 2009;35:203–8.

20. NicholsJJ,BerntsenDA,MitchellGL,NicholsKK.Anassessmentof grading scales for meibography images. Cornea. 2005;24:382–8.

21. Kasparov A.A., Kasparova Evg, Pavluk A.S. [Local express autotsitokinoterapy (complex cytokine) in the treatment of viral and nonviral eye lesions.]. Lokal’naja jekspress-autocitokinoterapija (kompleks citokinov) v lechenii virusnyh i nevirusnyh porazhenij glaz. [Annals of Ophthalmology]. Vestnik oftal’mologii. 2004;1:29-32.(in Russ.).

22. Kasparova E.A., Kasparova Evg.A., Kasparov A.A. [Modern clinic and treatment of adenoviral keratoconjunctivitis. Effective pharmacology]. Sovremennaja klinika i lechenie adenovirusnogo keratokon'junktivita. Jeffektivnaja farmakologija. [Ophthalmology]. Oftal’mologija. 2015;30(1):12-18. (in Russ.).


Review

For citations:


Trubilin V.N., Polunina E.G., Markova E.Yu., Andzhelova D.V., Kurenkova S.V., Bezmel’nitsyna L.Yu. Methods of Screening for Meibomian Gland Dysfunction. Ophthalmology in Russia. 2016;13(4):235-240. (In Russ.) https://doi.org/10.18008/1816-5095-2016-4-235-240

Views: 1572


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)